THC Farmaceuticals, Inc. (CBDG)
| Market Cap | 505.87K +39.5% |
| Revenue (ttm) | 18.52K -1.5% |
| Net Income | -72.47K |
| EPS | -0.01 |
| Shares Out | 18.13M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,000 |
| Open | 0.0280 |
| Previous Close | 0.0279 |
| Day's Range | 0.0279 - 0.0280 |
| 52-Week Range | 0.0022 - 0.0930 |
| Beta | -9.48 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About THC Farmaceuticals
THC Farmaceuticals, Inc. owns and operates non-financial institution cash-dispensing automated teller machines at third-party owned retail and commercial locations. The company’s machines are placed in hotels, stores, bowling alleys, and other high customer traffic areas for small and medium sized businesses. As of June 30, 2015, it had a total of eight machines for public use along the Wasatch Front in the State of Utah. The company was formerly known as City Media, Inc. and changed its name to THC Farmaceuticals, Inc. in February 2015. THC Fa... [Read more]
Financial Performance
In fiscal year 2014, THC Farmaceuticals's revenue was $19,034, a decrease of -12.04% compared to the previous year's $21,640. Losses were -$30,697, 28.8% more than in 2013.
Financial StatementsNews
Legendary Hero Senator Mike Gravel Ended Final Career As Chairman and CEO of THC Farmaceuticals, Inc When He Passed Away This Weekend
Thousand Oaks, CA, June 28, 2021 (GLOBE NEWSWIRE) -- CBDual Biotechnology Corp's parent company, THC Farmaceuticals, Inc (OTC: CBDG), developer of a unique line of premium CBD based oral health produc...